Currently there are no upcoming events.
Drs. Lewis Lanier and Oscar Aguilar of UCSF discuss new horizons in cellular therapy to fight cancer.
Three CRI ImmunoAdvocates discuss redefining and navigating their lives after cancer immunotherapy.
By monitoring a variety of factors, especially at the genetic and genomic levels, blood tests may give doctors deep insights into a person’s cancer and their immune health.
Dr. Kunle Odunsi of Roswell Park discusses what might lie ahead for the field in 2021—and what it means for patients.
Discover the microscopic organisms that inhabit our bodies and new microbiome-based treatment strategies in the clinic.
Discover how doctors and patients can recognize and safely manage an overstimulated or misdirected immune response with Dr. Jeffrey S. Weber of NYU Langone Health.
Discover the full potential of genome-based medicine with genomic and genetic testing for cancer risk and tumor assessment with Corrie Painter, Ph.D., and Eliezer Van Allen, M.D.
Discover antibody-based imaging strategies that help doctors visualize patients’ tumors and immune cells in real-time via PET scans.
Dr. Padmanee Sharma of MD Anderson discusses what breakthroughs and advances might lie ahead for the field of cancer immunotherapy in 2020.
Dr. Michel Sadelain of Memorial Sloan Kettering highlights a revolutionary new treatment approach—CAR T cell immunotherapy—that he helped pioneer.
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111
Dr. Kunle Odunsi, of the University of Chicago Medicine Comprehensive Cancer Center, answers questions about immunotherapy clinical trials after the 2021 CRI Virtual Immunotherapy Patient Summit.
Dr. Ellen Puré, of the University of Pennsylvania, answers questions about the basics of immunotherapy after the 2021 CRI Virtual Immunotherapy Patient Summit.